PSEUDOMYXOMA PERITONEI – AN ENDOSCOPIC IMAGE by Mehmood, Shafqat et al.
JOURNAL OF CANCER & ALLIED SPECIALTIES 1
IMAGES IN ONCOLOGYJ Cancer Allied Spec 2015;1(1):9
PSEUDOMYXOMA PERITONEI – AN ENDOSCOPIC IMAGE
Shafqat Mehmood1, Syed Aamir Ali Shah2, Syed Ather Kazmi3, Faisal Zeb1
1Departments of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre Lahore, 
Pakistan, 2Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre 
Lahore, Pakistan, 3Department of Medical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research 
Centre Lahore, Pakistan
Correspondence: Dr. Shafqat Mehmood, Department of Internal 
Medicine, Shaukat Khanum Memorial Cancer Hospital and Research 
Centre, Johar Town, Lahore, Pakistan.  
Email: smehmood@skm.org.pk
A 61-year-old male presented to our department with a 
history of worsening abdominal distention for the past 
1 month. Initial ultrasound abdomen showed debrinous 
ascites with loculations. A computed tomography (CT) 
imaging of the chest and abdomen was done with I/V 
contrast that showed gross peritoneal thickening and 
omental cake formation with deposits in peritoneum 
suggestive of pseudomyxoma peritonei. CT-guided biopsy 
of the omentum was performed which was reported 
as metastatic mucinous adenocarcinoma of unknown 
primary.
The patient was planned for upper and lower 
gastrointestinal (GI) endoscopies to rule out primary 
tumour in the GI tract. Upper GI endoscopy was normal; 
however, colonoscopy showed polypoidal growth at the 
orifice of appendix [Figure 1]. Multiple biopsies were 
taken. A laparotomy was performed which showed 
massive ascites with myxomatous fluid and omental cake 
formation. In addition to this, there was a nodular mass 
involving the appendix. A limited right hemicolectomy, 
omentectomy and debulking surgery were performed. 
Histopathology of the appendix showed mucinous 
adenocarcinoma. The patient was discharged home after 
a week with an appointment in medical oncology clinic 
for adjuvant treatment.
Pseudomyxoma peritonei is a rare disease process 
characterised by copious amount of mucinous ascites and 
histologically bland peritoneal mucinous tumour.[1] It is 
mostly appendicular in origin. The treatment option for 
this tumour includes repeated abdominal surgeries and 
cytoreductive approach, which includes intraoperative 
and perioperative chemotherapy.[2,3] The overall prognosis 
is guarded and only a small percentage of the patients 
are alive at 5 years.[1,2] In conclusion, pseudomyxoma 
peritonei is a rare disease, usually of appendiceal in origin 
and can be diagnosed effectively on colonoscopy.
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Figure 1: Colonoscopic image showing tumour of the 
appendix
